human papilloma virus hp primary etiolog agent response service cancer woman although total highrisk strain identify far current avail commerce vaccine design target mainly viral common assoc high level antigen specify caps antigen suitable provide crossprotect due increase report case crucial design vaccine genre reason cd cell response possible aim develop compute workflow identify conserve crossclad candid consider e protein set immunogen peptide fragment suppose protect infect across globe electron supplementary mater online version article dois contain author user 